Findings seen among adult outpatients with SARS-CoV-2 with oxygen saturation of 92 percent or greater
Ebola Outbreak in Democratic Republic of the Congo Declared Over
Wednesday marks 42 days, or two incubation periods, since the last survivor tested negative for the virus
U.S. FDA Reaffirms Commitment to COVID-19 Vaccine Transparency
While Emergency Use Authorizations (EUA) have received increased attention during the COVID-19 public health emergency, they are not a new tool to the US Food and Drug Administration (FDA).
The Commissioner of FDA Stephen M. Hahn M.D., took a moment on November 17, 2020, to reaffirm FDA’s commitment to transparency around the EUA process and share some updates on our plan to provide more information about FDA’s decisions to issue, revise or revoke EUAs for vaccines.
Cervical Cancer Prevention Investments Produce Significant ROI
The World Health Organization (WHO) Global Strategy to Accelerate the Elimination of Cervical Cancer announced today marks the first time that 194 countries commit to eliminating cancer – following the adoption of a resolution at the World Health Assembly in 2020.
Cervical cancer is a preventable disease that is also curable if detected early and adequately treated. Yet it is the 4th most common cancer among women globally.
This WHO cervical cancer strategy outlines three key steps: vaccination, screening, and treatment.
Sixty-Day Outcomes Examined for Hospitalized COVID-19 Patients
29.2 percent died during hospitalization or within 60 days of discharge; ongoing morbidity was common
Routine COVID-19 Testing Improves Safety of Elective Surgery
Benefits of nasal swab testing seen in high-transmission areas and before major surgery
Nebulized Interferon Beta-1a Promising for COVID-19
Adults hospitalized for COVID-19 receiving SNG001 versus placebo more likely to show clinical improvement
Persistent Fatigue Prevalent After COVID-19 Infection
More than half of those recovered from acute phase of COVID-19 experience postviral fatigue, independent of COVID-19 severity
Hospital Mortality Higher for Critically Ill With COVID-19 Versus Flu
Patients with COVID-19 have slower improvement in oxygenation, longer duration of mechanical ventilation, lower rates of extubation
India and Texas Partner to Develop COVID-19 Vaccine
A Hyderabad-based vaccine and pharmaceutical company announced the initiation of a Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India following approval from the Drugs Controller General of India.
This early-stage study’s results are expected to be available by February 2021.